Figure 4.
Predicted rivaroxaban plasma concentrations after the first dose (A) and during steady‐state (B) of rivaroxaban 20 mg day−1 in healthy volunteers
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.